Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PHASE II STUDY OF THE SAFETY AND EFFICACY OF TOREMIFENE IN THE THERAPY OF DESMOID TUMORS

NCT00002595 is registered in ClinicalTrials.gov with Advocate Lutheran General Hospital as lead sponsor.

NCT NCT00002595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PHASE II STUDY OF THE SAFETY AND EFFICACY OF TOREMIFENE IN THE THERAPY OF DESMOID TUMORS
Lead sponsor
Advocate Lutheran General Hospital
Phase
Phase 2
Overall status
Completed
Start date
July 31, 1991
Completion date
September 30, 2010
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

desmoid tumor